Food and Drug Administration

  1. 10 Developments By Gilead Sciences That Could ...

    Learn about 10 drugs in the pipeline for Gilead Sciences, and learn how it has acquired ...
  2. How to Profit from the Generic Drug Trend

    Generic drugs are poised to steal market share as patent protections on a number ...
  3. How Does Biogen Make its Money?

    Biogen is a healthy biotechnology company producing a stream of illness-fighting ...
  4. How NDAs Work and Why They're Important

    A non-disclosure agreement, or NDA, is a legal document that keeps the lid on sensitive ...
  5. Could Amgen's Next Drug Be Worth $100 Billion?

    Amgen hopes it will win an FDA green light for evolocumab, a next-generation cholesterol ...
  6. 3 Things That Could Hold Intuitive Surgical Back

    Taking a long-term view that favors Intuitive Surgical developer increasing in value, ...
  1. 10 Developments By Gilead Sciences That Could ...

    Learn about 10 drugs in the pipeline for Gilead Sciences, and learn how it has acquired ...
  2. How to Profit from the Generic Drug Trend

    Generic drugs are poised to steal market share as patent protections on a number ...
  3. How Does Biogen Make its Money?

    Biogen is a healthy biotechnology company producing a stream of illness-fighting ...
  4. Could Amgen's Next Drug Be Worth $100 Billion?

    Amgen hopes it will win an FDA green light for evolocumab, a next-generation cholesterol ...
  5. 3 Things That Could Hold Intuitive Surgical Back

    Taking a long-term view that favors Intuitive Surgical developer increasing in value, ...
  6. Did Orexigen Make A Big Mistake?

    Developing drugs isn't cheap. Drugmakers spend $1.4 billion in direct costs to bring ...
  1. What are the primary factors that drive share prices in the drugs sector?

    Learn about the primary factors that drive share prices in the drug sector. Creating and manufacturing drugs is a complex ...
  2. What countries comprise the majority of the global drugs sector?

    Find out which countries are the largest producers of pharmaceutical products in the world and why the United States dominates ...
  3. What are the major barriers to entry for new companies in the drugs sector?

    Find out why barriers to entry for U.S. drug companies are so high and how the Food and Drug Administration, or FDA, inhibits ...
  4. How does the strength of the IPO market affect the drugs sector?

    Discover how the strength of the IPO market affects the drugs sector. A strong IPO market reflects healthy risk appetites ...
Trading Center
×

You are using adblocking software

Want access to all of Investopedia? Add us to your “whitelist”
so you'll never miss a feature!